Stem Cell Applications

In 2015 alone Animal Medical Centre Kuala Lumpur, was presented with 280 cases of debilitating lameness and paresis. These cases ranged from dogs with inherited disease resulting in early developing osteoarthritis and includes geriatric pets with end stage spinal and hip osteoarthritis. The limited response to conventional medical and surgical options prompted Dr Amilan Sivagurunathan and his team of senior veterinarians to pursue alternative technologies and trends with the hope of implementing novel and therapeutic technologies to benefit these patients. One of the technologies used in our stem cell application is from MediVet Biologics.
MediVet Biologics developed the first in-clinic Adipose Stem Cell Therapy kit. They continue to make advancements in veterinary regenerative medicine and biological therapeutic offerings for both equine and small animal applications. MediVet’s Adipose-Derived Stem Cell Procedure kit is a major scientific advancement in animal stem cell therapy that offers an economic solution for owners of pets suffering from osteoarthritis, hip dysplasia, ligament and cartilage injuries as well as numerous mobility ailments.
MediVet’s accomplishments in the regenerative medicine market have given way to an incredible pipeline of technological advancements and the ability to successfully bring those animal health products to market. MediVet is the only Veterinary Regenerative Medicine company to have multiple collaborative university studies further validating current technology and product pipelines. Their work boasts extensive collections of anecdotal evidence of efficacy through clinical cases and field reporting. They continue to provide concrete validation in all MediVet Biologics’ endeavors.

Stem cell applications via, autologous adult mesenchymal stem cell (ADMSC) therapy, provides promise for many animals that have undergone this treatment with the following benefits:

  1. 1. Reduction of dependence on NSAID (pain medications). Long term use has
  2.     been widely known to results in a list of side effects to the gastrointestinal
  3.     tract , Renal function and Liver function.
  4. 2. An alternative prior to surgical intervention. Surgery is often considered the
  5.     end stage/last procedure considered in the management of hip  dysplasia.
  6.     Some patients may not be in the best of health to undergo major
  7.     orthopaedic correction.
  8. 3. A novel and proven method of biological pain control.
  9. 4. The option of stem cell banking allows the use of ADMSC in multiple
  10.     planned treatments for canine and feline osteoarthritis.

Our latest study on ADMSC us in MALAYSIA is currently being published. We will be pursuing more investigations on the following diseases areas:

  1. 1. Feline Bronchial Asthama
  2. 2. Heart Disease
  3. 3. Liver Disease
  4. 4. Kidney Disease
  Stem Cell Article